Braveheart Bio, Inc.
S-1 FiledBRVE
Braveheart Bio, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$100M
Exchange
—
Ticker: BRVE
Status
S-1 Filed
Filed
Jul 15, 2026
IPO timeline
Jul 15, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is Braveheart Bio, Inc. going public?
Braveheart Bio, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Braveheart Bio, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Braveheart Bio, Inc. list on?
No exchange has been officially announced for the Braveheart Bio, Inc. IPO.
Has Braveheart Bio, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Braveheart Bio, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR